Dartmouth-Hitchcock, Geisel School of Medicine, and State, Regional and National Cancer Experts Partner to Present the New Hampshire Childhood Cancer Conference June 10, 2021
Meet DHMC's new Chief Research Officer
Charles R. Thomas, Jr., MD, Named Chief of Radiation Oncology at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center
After an extensive national search, Dartmouth and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) has named Charles R. Thomas, Jr., MD, as the new Chief of the Section of Radiation Oncology
Dartmouth and Dartmouth-Hitchcock Cancer Researchers Discover Cutting-Edge Approach to Fighting a Form of Deadly Cancer
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients
Norris Cotton Cancer Center and Other Top U.S. Cancer Centers Call for Urgent Action to Get Cancer-Preventing HPV Vaccination Back on Track
Dartmouth’s and D-H's Norris Cotton Cancer Center is partnering with 70 other National Cancer Institute designated cancer centers to issue a joint statement urging the nation’s physicians, parents and young adults to get the HPV vaccination back on track.
The Friends of Norris Cotton Cancer Center announce a hybrid Prouty event, with in-person and virtual participation options available this summer. Registration is open at TheProuty.org.
Dartmouth-Hitchcock Department of Surgery Chair Elected President-Elect of the Society of Surgical Oncology
The Society of Surgical Oncology announced that Sandra L. Wong, MD, MS, FSSO, is its president-elect.
Researchers at Norris Cotton Cancer Center Are Studying the Use of Estrogen to Target Drug-Resistant Breast Cancer
An ongoing clinical trial at NCCC will determine whether the strategy of cycling between estrogen therapy and anti-estrogen therapies is effective in human patients with advanced breast cancer.
Three teams receive awards from the Dartmouth Innovations Accelerator for Cancer
NH Cancer Researchers Find Cellular Evidence Behind Lasting Immune Response in Some Cancer Survivors
Researchers have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.